Endocannabinoid System and Adolescent Psychiatric Risk
Clinical Takeaway Adolescents who use cannabis face significantly elevated risks of developing psychotic disorders, bipolar disorder, depression, and anxiety disorders in both adolescence and young adulthood, based on longitudinal population-level…
Adolescent Cannabis Use: Psychotic Disorder Risk Guide
Clinical Takeaway Adolescents who use cannabis show increased risk of developing clinically diagnosed psychotic, bipolar, depressive, and anxiety disorders during adolescence and early adulthood compared to non-users. This association persists in large…
Endocannabinoid System Research: Teen Cannabis and Mental Health
Clinical Takeaway Adolescent cannabis use is associated with increased risk of developing psychotic, bipolar, depressive, and anxiety disorders, based on large-scale longitudinal population data tracking clinically diagnosed outcomes rather than…
Endocannabinoid System Research: Teen Cannabis & Mental Health
Clinical Takeaway Adolescent cannabis use is associated with significantly increased risk of developing psychotic, bipolar, depressive, and anxiety disorders in adolescence and young adulthood, based on large-scale longitudinal population data. These…
Young Adult Substance Use Affects Memory at 65 – Neuroscience News
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic MemoryYoung AdultsLongitudinal…